Skip to main content
. 2020 Nov 11;73(9):e3227–e3234. doi: 10.1093/cid/ciaa1701

Table 2.

Percentage of Men With Persistent Oral HPV Infections at the 6-, 12-, 18-, and 24-Month Clinical Visits

HPV Type No. of Men Positive at First Visit Persistence at Second Visit (Month 6) (N = 184), n (%) Persistence at Third Visit (Month 12) (N = 184), n (%) Persistence at Fourth Visit (Month 18) (N = 173), n (%) Persistence at Fifth Visit (Month 24) (N = 161), n (%)
16 50 18 (36.0) 14 (28.0) 12 (24.0) 9 (18.0)
18 14 2 (14.3) 2 (14.3) 3 (21.4) 1 (7.1)
31 10 3 (30.0) 4 (40.0) 3 (30.0) 3 (30.0)
33 5 3 (60.0) 2 (40.0) 1 (20.0) 1 (20.0)
35 8 4 (50.0) 3 (37.5) 2 (25.0) 1 (12.5)
39 22 14 (63.6) 11 (50.0) 8 (36.4) 7 (31.8)
45 8 4 (50.0) 2 (25.0) 1 (12.5) 1 (12.5)
51 31 10 (32.3) 7 (22.6) 6 (19.4) 6 (19.4)
52 23 7 (30.4) 3 (13.0) 3 (13.0) 2 (8.7)
56 17 8 (47.1) 5 (29.4) 5 (29.4) 4 (23.5)
58 7 1 (14.3) 2 (28.6) 2 (28.6) 1 (14.3)
59 7 6 (85.7) 4 (57.1) 4 (57.1) 1 (14.3)
68/73 2 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
High-risk HPV 184 76 (41.3) 58 (31.5) 49 (26.6) 37 (20.1)
Low-risk HPV 105 4 (3.8) 4 (3.8) 4 (3.8) 3 (2.9)

Any visit without detected HPV but preceded by a visit with positive infection and followed by 2 visits with positive infection was considered positive for a given HPV genotype (ie, +–+ +). Abbreviation: HPV, human papillomavirus.